Sopharma stock trades higher on BSE Sofia turnover

Sopharma stock (BG11SOSOBT18) traded on BSE Sofia with EUR 164,076 in turnover and 68,625 lots on September 4, 2026, while the issuer page in Sofia showed a close of BGN 3.7845 and a daily change of minus 0.26 percent. The companys ticker is SFA, and the Bulgarian exchange data also placed it among the most traded names of the session.

Trading activity stands out

On the issuer profile, Sopharma accounted for 42 trades and EUR 89,498 in turnover, alongside 46,937 lots, on the same market snapshot. That gives investors a concrete read on liquidity: a mid-cap name that still draws repeated trading, even when the price is little changed.

The market context is more important than any single tick. With the shares at BGN 3.7845 on September 5, 2026, the stock was moving inside a narrow daily range and the session change remained small.

Latest reported numbers

Sopharma last reported full-year 2025 figures showing revenue of BGN 1.07 billion and net profit of BGN 112.6 million, both part of the most recently published annual results. The company also said operating EBITDA reached BGN 196.2 million in 2025, which was higher than the prior year and keeps the business on a profitable base.

For comparison, 2024 revenue was BGN 982.2 million and net profit was BGN 101.5 million. That means revenue rose by BGN 87.8 million year on year, while profit increased by BGN 11.1 million.

Product and portfolio

Sopharma remains a diversified pharmaceutical group with a broad OTC and prescription portfolio, and the market still values the recurring cash flow from that mix. In a small-cap context, the combination of drug sales, manufacturing and distribution is what supports trading interest around the Sofia listing.

Price level in Sofia

At BGN 3.7845 as of September 5, 2026, Sopharma shares remained close to the latest daily trading band on BSE Sofia. For investors, the key point is the combination of BGN 3.7845 price, EUR 164,076 turnover and BGN 1.07 billion in 2025 revenue, which keeps the stock easy to follow and still fundamentally grounded.